~~<i id='946F51634A'><strike id='946F51634A'><tt id='946F51634A'><pre id='946F51634A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：hotspot 2025-09-02 22:26:08 - browse：24

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Trump indictment: Who are the 'co

explore

entertainment

hotspot

focus

Wikipedia

entertainment

UnitedStates'AlexMorgan(13)andSavannahDeMelo(9)celebrateagoalbyteammateSophiaSmithduringthefirsthalf

WSS

Inside the culture of fear in the White House science office of Eric Lander

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Sage hopes for a blockbuster in antidepressant now before FDA

What to expect as Trump is arraigned on his Jan 6. indictment

Doctors have an ethical obligation to be advocates

knowledge

fashion

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Burning questions about Delta and the next phase of the Covid pandemic

Psychedelics group wrestles with new pharma identity

Severe heat forecast: Where scorching temperatures will persist over the next week

Medical leaders decry Supreme Court decision on affirmative action

NIH launches clinical trials and new research office for long Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Breakthrough Alzheimer’s drugs are inaccessible in rural states

United colonoscopy coverage change 'may cost lives,' doctors say

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

entertainment

The high personal cost of affirmative action for Black doctors

Breakthrough Alzheimer’s drugs are inaccessible in rural states

What the US credit downgrade means for the economy, your finances

New safety details link Apellis eye drug to rare cases of blindness

Novartis develops a rapidly manufactured CAR

Mega Millions pot grows to $1.25 billion after no winner

hotspot

focus

Wikipedia

entertainment